Educational Mission Report:

This is to report that I attended the Key Opinion Leaders (KOL) Symposium for renal failure and dialysis in Beirut - Lebanon from 7^th – 10^th September 2015, participating in all sessions and meetings scheduled in that symposium; which were presented in two main parts:

Part 1:    AKI: A problem of Today and Tomorrow

Day 1: Monday 7^th September;

Session 1, Lecture 1: The Burden of Acute Kidney Injury (AKI), by: Dr. Jose L. Perez Fernandez, Hospital Universitario de Bellvitge, Barcelona – Spain.

Session 1, Lecture 2: Impact of Renal Replacement Therapy (RRT) Modality on Renal Recovery after AKI, by: Dr. Kai Harenski, Medical Director EMEA, Baxter International.

Session 1, Lecture 3: Long-Term Dialysis Dependence after AKI: Clinical and Health-Economic Implications, by: Dr. Jose L. Perez Fernandez.

Session 2, Lecture 1: AKI in Critically Ill Patients: How to Define the Right Timing for RRT? by: Dr. Chris Kirwan, Royal London Hospital, London – United Kingdom.

Session 2, Lecture 2: Anticoagulant Strategies during Continuous Renal Replacement Therapy (CRRT), by: Dr. Tobias M. Bingold, University Hospital Frankfurt, Frankfurt am Main, Germany.

Session 2, Lecture 3: Regional Citrate Anticoagulation: High and Low Concentrated Solutions, by: Dr. Kai Harenski.

Workshop: The View of the Experts, Clinical Cases – workshop 1, by: Dr. Tobias M. Bingold and Dr. Jose L. Perez Fernandez.

Day 2: Tuesday 8^th September;

Session 3, Lecture 1: Mechanisms of Septic AKI, by: Dr. Tobias M. Bingold.

Session 3, Lecture 2: Extra-Corporeal Treatment Options in Sepsis, by: Dr. Jose L. Perez Fernandez.

Session 3, Lecture 3: The Role of CRRT in the Management of Fluid Overload, by: Dr. Chris Kirwan

Session 4, Lecture 1: Nutritional Support during CRRT, by: Dr. Chris Kirwan.

Session 4, Lecture 2: Limitations of Lung Protective Ventilation (LPV) in ARDS Patients, by: Dr. Kai Harenski.

Session 4, Lecture 3: Extra-Corporeal CO₂ Removal (ECCOR) Therapies: Indications and Future Perspectives, by: Dr. Tobias M. Bingold.

Workshop: The View of the Experts, Clinical Cases – workshop 2, by: Dr. Chris Kirwan.

Part 2:   Advances in the Treatment of Renal Failure: Meeting the Clinical Needs

Day 1: Wednesday 9^th September;

Session 1, Lecture 1: International Trends in End-Stage-Renal-Disease (ESRD) Management and Recent Randomized Clinical Trials in Dialysis, by: Prof. Paul Cockwell, Professor of Nephrology, University of Birmingham – United Kingdom.

Session 1, Lecture 2: Practical Challenges in Optimizing Peritoneal Dialysis (PD). by: Dr. Lukas Foggensteiner, Consultant Nephrologist University Hospitals Birmingham – United Kingdom.

Session 2, Lecture 1: How to Improve Early Outcomes of Renal Replacement Therapies? by: Prof. Maurice Laville, Professor of Nephrology and Therapeutics, Lyon University, France.

Session 2, Lecture 2: Hemodialysis Adequacy Revisited: How Adequate the Parameters Are? by: Prof. Antoine Barbari, Chair of Internal Medicine Department, Rafik Hariri University Hospital, Lebanon.

Session 3, Lecture 1: PD Case Study. by: Dr. Lukas Foggensteiner

Session 3, Lecture 2: Clinical Discussion: Initiation of Dialysis – Therapy Selection. By The Panel.

Day 2: Thursday 10^th September;

Session 4, Lecture 1: Advances in Membranes for Dialysis, by: Dr. Werner Beck, Director Medical Affairs, Baxter Company.

Session 4, Lecture 2: Managing High Bleeding Risk Patients – Current Practice and Implications of the HepZero Trial Results, by: Prof. Maurice Laville.

Session 5, Lecture 1: Managing Inflammation in Patients with End-Stage-Renal-Disease (ESRD), by: Prof. Paul Cockwell.

Session 5, Lecture 2: RRT : The Continuum of Care, by : Dr. Kamel El-Attar, Sr. Chronic Marketing Manager, Baxter MEA.

Session 6, Lecture 1: Optimizing the Haemodialysis Patient Journey, by: Prof. Mohamed Hany Hafez, Professor of Nephrology - Cairo University, President Elect ESNT, Egypt.

Session 6, Lecture 2: Clinical Discussion: Inadequate Therapy – Therapy Change, By The Panel.